- Home
- CPAY vs BNTX Comparison
CPAY vs BNTX Comparison
Compare CPAY & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPAY | BNTX |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7B | 24.8B |
| IPO Year | 2010 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CPAY | BNTX |
|---|---|---|
| Price | $308.35 | $92.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $375.50 | $137.40 |
| AVG Volume (30 Days) | 602.6K | ★ 1.5M |
| Earning Date | 02-04-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.04 | N/A |
| EPS | ★ 14.72 | N/A |
| Revenue | ★ $4,314,608,000.00 | $3,698,814,972.00 |
| Revenue This Year | $15.86 | $2.36 |
| Revenue Next Year | $15.55 | N/A |
| P/E Ratio | $21.05 | ★ N/A |
| Revenue Growth | ★ 11.27 | 3.70 |
| 52 Week Low | $252.84 | $81.20 |
| 52 Week High | $400.81 | $129.27 |
Technical Indicators
Market Signals| Indicator | CPAY | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.47 | 35.58 |
| Support Level | $308.04 | $91.11 |
| Resistance Level | $315.94 | $93.76 |
| Average True Range (ATR) | 7.58 | 2.08 |
| MACD | -0.06 | -0.33 |
| Stochastic Oscillator | 57.60 | 15.27 |
Price Performance
Historical ComparisonAbout CPAY Corpay Inc.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.